IFNG and neoplasm: In mouse xenograft models of breast cancer, artemisinin remarkably reduced the number of Treg in tumor matrix, and increased the proportion of IFN-γ/I-4 in the supernatant of spleen cells [124], leading to the inhibition of the immune microenvironment on tumor development.